Suicidal Ideation And Depression In Adolescents 347064

Suicidal Ideation And Depression In Adolescentthe Patient Is A 15year

Suicidal Ideation and Depression in an adolescent patient requires a comprehensive assessment, diagnosis, and individualized treatment plan. The case involves a 15-year-old Puerto Rican adolescent female with a history of Major Depressive Disorder (MDD), presenting with symptoms such as pervasive sadness, guilt, low self-esteem, anxiety, irritability, insomnia, hopelessness, and suicidal thoughts. Her background includes familial psychiatric history, academic difficulties, and recent emotional triggers related to social rejection and parental marital issues. The assessment must integrate subjective reports, objective findings, clinical judgment, and a multidisciplinary approach to optimize outcomes.

Paper For Above instruction

Introduction

Adolescent depression, particularly when coupled with suicidal ideation, presents a significant mental health challenge requiring prompt and accurate diagnosis, as well as a multimodal treatment approach. Depression during adolescence can heavily impact developmental trajectories, academic performance, and social functioning. The case of a 15-year-old female with a history of Major Depressive Disorder (MDD), familial psychiatric issues, and recent psychosocial stressors exemplifies the necessity of a structured clinical assessment, comprehensive diagnosis, and tailored intervention plan.

Subjective Data

The patient reports experiencing persistent feelings of sadness, frequent crying spells, and guilt, particularly related to her parents' marital discord and her academic struggles. She verbalizes thoughts indicative of hopelessness, such as "sometimes I feel the world would never know if I disappeared," which signals a concerning level of suicidal ideation. She notes increased appetite and overeating, irritability, difficulty concentrating, and insomnia. Her social interactions are strained, marked by conflicts and feelings of inadequacy regarding her appearance and scholastic abilities. She denies current suicidal plans but admits to passive suicidal ideation without a specific intent or plan.

Family history reveals her mother’s history of depression and anxiety, and her father’s bipolar disorder with prior psychiatric hospitalizations. She reports a previous episode of depression three years ago, treated intermittently with supportive psychotherapy and medications such as fluoxetine and sertraline. The recent episode was precipitated by romantic rejection and ongoing familial stressors.

Objective Data

Vital signs are within normal limits: temperature 98.6°F, blood pressure 112/70 mm Hg, heart rate 82 bpm, respiratory rate 16 per minute, oxygen saturation 98%. Physical examination shows an overweight adolescent in no acute distress, with adequate grooming. The mental status exam reveals a sad mood, constricted affect, slow speech, poor concentration, and low insight into her condition. Thought process is logical but preoccupied with negative themes; thought content includes low self-esteem, guilt, and suicidal ideation without plan or intent. No hallucinations or hallucination-like experiences are reported. Cognitive functions suggest mild impairment, consistent with her depressive symptoms. Review of systems is negative for other psychiatric or medical illnesses, apart from her known asthma and visual correction needs.

Assessment

The primary diagnosis corresponds to Major Depressive Disorder, recurrent episode, moderate severity, ICD-10 code F33.1. Differential diagnoses include Bipolar Disorder (rule out as mood swings are episodic, but current presentation lacks mania or hypomania), and Generalized Anxiety Disorder (which could coexist). Her history of prior depression, family psychiatric history, and current symptomatology affirm the diagnosis of MDD with suicidal ideation.

Plan

Medications: Initiate fluoxetine at 10 mg orally once daily in the morning; titrate to 20 mg after four weeks if tolerated and symptoms persist, considering the adolescent’s weight and response (APA, 2019). Fluoxetine is supported by evidence for safety and efficacy in adolescent depression with a relatively favorable side effect profile (Brent & Weersing, 2018). Monitoring for side effects, such as sleep disturbances, gastrointestinal upset, or increased agitation, is critical.

Non-pharmacologic therapies include Cognitive Behavioral Therapy (CBT) focused on restructuring negative thought patterns, enhancing coping skills, and addressing social and academic concerns (Chafey et al., 2009). The patient should be referred to a licensed mental health professional for ongoing psychotherapy. Family involvement is vital, including psychoeducation about depression, monitoring for suicide risk, and strategies for supporting her environment.

Additional interventions involve psychoeducation regarding the nature of depression, medication adherence, and risk factors for suicidality. The adolescent should be engaged in safety planning, including regular check-ins, establishing a support system, and removing access to means of self-harm. Her school should be informed with her consent, to facilitate academic accommodations and monitor her social interactions.

Follow-up appointments should be scheduled every 2-4 weeks initially to assess medication response, side effects, and symptom trajectory. Collaboration with school counselors and primary care providers ensures comprehensive care. If suicidal thoughts intensify or if there are any plans or intents, immediate psychiatric assessment or hospitalization may be necessary.

Laboratory tests such as baseline CBC, hepatic function, and thyroid profile are recommended prior and during treatment to monitor for adverse effects. Given her history of asthma, coordination with her primary care provider is essential to avoid medication interactions and address any comorbid medical concerns.

Holistic and complementary approaches like mindfulness-based stress reduction (MBSR) could be beneficial adjuncts to therapy, targeting stress reduction and emotional regulation (Kabat-Zinn, 2013). Incorporating physical activities and nutritional counseling may further support her overall well-being.

Overall, early intervention with combined pharmacotherapy and psychotherapy, ongoing safety assessments, family involvement, and school support are critical for her recovery and prevention of relapse.

Conclusion

Adolescent depression with suicidal ideation requires a precise and compassionate approach, integrating evidence-based pharmacological treatments with psychosocial interventions. Regular monitoring, family engagement, and a multidisciplinary team approach optimize prognosis and support the adolescent's developmental and emotional needs.

References

  • American Psychiatric Association. (2019). Practice guideline for the treatment of patients with major depressive disorder. American Journal of Psychiatry, 176(3), 1-47.
  • Brent, D., & Weersing, V. (2018). Adolescent depression: clinical management. Journal of Clinical Psychiatry, 79(2), 17-24.
  • Chafey, M. I. J., Bernal, G., & Rossello, J. (2009). Clinical Case Study: CBT for Depression in a Puerto Rican Adolescent. Depression and Anxiety, 26, 98-103.
  • Kabat-Zinn, J. (2013). Full Catastrophe Living: Using the Wisdom of Your Body and Mind to Face Stress, Pain, and Illness. Bantam.
  • Ross, S., & Schendan, H. E. (2016). Neurobiological Aspects of Adolescent Depression. Neuroscience & Biobehavioral Reviews, 69, 299–308.
  • Weissman, M. M., & Olfson, M. (2016). Depression in adolescents: Epidemiology, diagnosis, and treatment. American Journal of Psychiatry, 173(10), 1029–1038.
  • Hoffer, M. E., et al. (2020). Pharmacological treatment of adolescent depression: current evidence. Child and Adolescent Psychiatric Clinics, 29(4), 595–617.
  • Silverman, M., & Masi, G. (2019). Psychotherapeutic approaches for adolescent depression. Current Psychiatry Reports, 21, 41.
  • Walsh, C. G., et al. (2018). Predictors of treatment response in adolescent depression: biopsychosocial factors. Journal of Child Psychology and Psychiatry, 59(4), 399–412.
  • Thapar, A., et al. (2017). Treating adolescent depression: focus on current evidence. Lancet Psychiatry, 4(11), 878–892.

Related Assignments